_id

690f374cccc777a4e85d17d3

Ticker

BNTC

Name

Benitec Biopharma Ltd ADR

Exchange

NASDAQ

Address

3940 Trust Way, Hayward, CA, United States, 94545

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://benitec.com

Description

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Last Close

12.96

Volume

225505

Current Price

12.92

Change

-0.30864197530864906

Last Updated

2025-11-28T13:03:17.491Z

Image

-

Ipo Date

2015-08-18T00:00:00.000Z

Market Cap

440716864

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8671900000000001

Sentiment Sources

10

Rating

4.5714

Target Price

25.8333

Strong Buy

4

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

178522.2

Gross Profit

-178522.2

Operating Expenses

14652436

Operating Income

-14830958

Interest Expense

-

Pretax Income

-13563148

Net Income

-13563148

Eps

-0.32665534395856777

Dividends Per Share

-

Shares Outstanding

33862226

Income Tax Expense

-

EBITDA

-13384626

Operating Margin

-

Total Other Income Expense Net

1267810.2

Cash

94479000

Short Term Investments

-

Receivables

7000

Inventories

-

Total Current Assets

95079000

Property Plant Equipment

873000

Total Assets

96027000

Payables

271000

Short Term Debt

414000

Long Term Debt

-

Total Liabilities

2428000

Equity

93599000

Depreciation

118000

Change In Working Capital

316000

Cash From Operations

-3351000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

0

Net Change In Cash

-3265000

PE

-

PB

5.7314174040320935

ROE

-14.4906975501875

ROA

-14.12430670540577

FCF

-3351000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

178522.2

Quarters > 0 > income Statement > gross Profit

-178522.2

Quarters > 0 > income Statement > operating Expenses

14652436

Quarters > 0 > income Statement > operating Income

-14830958

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-13563148

Quarters > 0 > income Statement > net Income

-13563148

Quarters > 0 > income Statement > eps

-0.32665534395856777

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

41521280

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-13384626

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1267810.2

Quarters > 0 > balance Sheet > cash

94479000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

7000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

95079000

Quarters > 0 > balance Sheet > property Plant Equipment

873000

Quarters > 0 > balance Sheet > total Assets

96027000

Quarters > 0 > balance Sheet > payables

271000

Quarters > 0 > balance Sheet > short Term Debt

414000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

2428000

Quarters > 0 > balance Sheet > equity

93599000

Quarters > 0 > cash Flow > net Income

-8965000

Quarters > 0 > cash Flow > depreciation

118000

Quarters > 0 > cash Flow > change In Working Capital

316000

Quarters > 0 > cash Flow > cash From Operations

-3351000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

-3265000

Quarters > 0 > ratios > PE

-0.32665534395856777

Quarters > 0 > ratios > PB

5.7314174040320935

Quarters > 0 > ratios > ROE

-14.4906975501875

Quarters > 0 > ratios > ROA

-14.12430670540577

Quarters > 0 > ratios > FCF

-3351000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

556000

Quarters > 1 > income Statement > cost Of Revenue

278000

Quarters > 1 > income Statement > gross Profit

278000

Quarters > 1 > income Statement > operating Expenses

17454000

Quarters > 1 > income Statement > operating Income

-17176000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-16147000

Quarters > 1 > income Statement > net Income

-16147000

Quarters > 1 > income Statement > eps

-0.4459355174535273

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

36209271

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-19020000

Quarters > 1 > income Statement > operating Margin

-3089.2086330935253

Quarters > 1 > income Statement > total Other Income Expense Net

1029000

Quarters > 1 > balance Sheet > cash

97744000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

33000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

98518000

Quarters > 1 > balance Sheet > property Plant Equipment

991000

Quarters > 1 > balance Sheet > total Assets

99592000

Quarters > 1 > balance Sheet > payables

201000

Quarters > 1 > balance Sheet > short Term Debt

354000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

2297000

Quarters > 1 > balance Sheet > equity

97295000

Quarters > 1 > cash Flow > net Income

-8805000

Quarters > 1 > cash Flow > depreciation

118000

Quarters > 1 > cash Flow > change In Working Capital

-5502889

Quarters > 1 > cash Flow > cash From Operations

-8528619

Quarters > 1 > cash Flow > capital Expenditures

470.61

Quarters > 1 > cash Flow > cash From Investing

-466.44

Quarters > 1 > cash Flow > cash From Financing

4278919

Quarters > 1 > cash Flow > net Change In Cash

-5789000

Quarters > 1 > ratios > PE

-0.4459355174535273

Quarters > 1 > ratios > PB

4.808302392928722

Quarters > 1 > ratios > ROE

-16.595919625880057

Quarters > 1 > ratios > ROA

-16.213149650574344

Quarters > 1 > ratios > FCF

-8529089.61

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-15.340089226618703

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

106000

Quarters > 2 > income Statement > gross Profit

-106000

Quarters > 2 > income Statement > operating Expenses

10082000

Quarters > 2 > income Statement > operating Income

-10188000

Quarters > 2 > income Statement > interest Expense

823000

Quarters > 2 > income Statement > pretax Income

-9354000

Quarters > 2 > income Statement > net Income

-9354000

Quarters > 2 > income Statement > eps

-0.24233504034370643

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

38599453

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-9248000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

834000

Quarters > 2 > balance Sheet > cash

103583000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

3000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

104010000

Quarters > 2 > balance Sheet > property Plant Equipment

1109000

Quarters > 2 > balance Sheet > total Assets

105209000

Quarters > 2 > balance Sheet > payables

433000

Quarters > 2 > balance Sheet > short Term Debt

346000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

7639000

Quarters > 2 > balance Sheet > equity

97570000

Quarters > 2 > cash Flow > net Income

-9354000

Quarters > 2 > cash Flow > depreciation

106000

Quarters > 2 > cash Flow > change In Working Capital

659000

Quarters > 2 > cash Flow > cash From Operations

-3086000

Quarters > 2 > cash Flow > capital Expenditures

6000

Quarters > 2 > cash Flow > cash From Investing

-6000

Quarters > 2 > cash Flow > cash From Financing

28414000

Quarters > 2 > cash Flow > net Change In Cash

25301000

Quarters > 2 > ratios > PE

-0.24233504034370643

Quarters > 2 > ratios > PB

5.111252769908783

Quarters > 2 > ratios > ROE

-9.586963205903453

Quarters > 2 > ratios > ROA

-8.890874354855573

Quarters > 2 > ratios > FCF

-3092000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

81000

Quarters > 3 > income Statement > gross Profit

-81000

Quarters > 3 > income Statement > operating Expenses

8529000

Quarters > 3 > income Statement > operating Income

-8610000

Quarters > 3 > income Statement > interest Expense

823000

Quarters > 3 > income Statement > pretax Income

-7357000

Quarters > 3 > income Statement > net Income

-7357000

Quarters > 3 > income Statement > eps

-0.33326792095357843

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

22075332

Quarters > 3 > income Statement > income Tax Expense

-7357000

Quarters > 3 > income Statement > EBITDA

-7276000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1253000

Quarters > 3 > balance Sheet > cash

78283000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

2000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

78713000

Quarters > 3 > balance Sheet > property Plant Equipment

288000

Quarters > 3 > balance Sheet > total Assets

79068000

Quarters > 3 > balance Sheet > payables

593000

Quarters > 3 > balance Sheet > short Term Debt

137000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

3127000

Quarters > 3 > balance Sheet > equity

75941000

Quarters > 3 > cash Flow > net Income

-7357000

Quarters > 3 > cash Flow > depreciation

81000

Quarters > 3 > cash Flow > change In Working Capital

-606000

Quarters > 3 > cash Flow > cash From Operations

-7703000

Quarters > 3 > cash Flow > capital Expenditures

12000

Quarters > 3 > cash Flow > cash From Investing

-12000

Quarters > 3 > cash Flow > cash From Financing

17872000

Quarters > 3 > cash Flow > net Change In Cash

10440000

Quarters > 3 > ratios > PE

-0.33326792095357843

Quarters > 3 > ratios > PB

3.7557220663409754

Quarters > 3 > ratios > ROE

-9.687783937530451

Quarters > 3 > ratios > ROA

-9.30464916274599

Quarters > 3 > ratios > FCF

-7715000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

37

Valuation > metrics > PE

-0.32665534395856777

Valuation > metrics > PB

5.7314174040320935

Valuation > final Score

22.685825959679065

Valuation > verdict

91.0% Overvalued

Profitability > metrics > ROE

-14.4906975501875

Profitability > metrics > ROA

-14.265135308532903

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.025940448081710275

Risk > metrics > Interest Coverage

-83.07636033654116

Risk > final Score

-272

Risk > verdict

High

Liquidity > metrics > Current Ratio

138.8014598540146

Liquidity > metrics > Quick Ratio

138.8014598540146

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

31.91697607071278

Prev Valuations > 1

28.887472300912165

Prev Valuations > 2

42.44277933659025

Prev Profitabilities > 0

0

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

36

Prev Risks > 1

10

Prev Risks > 2

18

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:29:12.299Z